Comparison of the Metabolite Profiles of HT-29 Colorectal Cancer Cells Treated with Curcumin, Cisplatin, 5-Fluorouracil and Doxorubicin in a Metabolomic Approach

Ade Arsianti; Innas Widiasti; Aryo Tedjo; Shun Hirota; Hiroki Tanimoto

doi:10.26538/tjnpr/v9i3.38

Comparison of the Metabolite Profiles of HT-29 Colorectal Cancer Cells Treated with Curcumin, Cisplatin, 5-Fluorouracil and Doxorubicin in a Metabolomic Approach

Ade Arsianti^*, Innas Widiasti, Aryo Tedjo, Shun Hirota, Hiroki Tanimoto

^*Corresponding author for this work

Biorecognition Chemistry

Research output: Contribution to journal › Article › peer-review

Original language	Japanese
Pages (from-to)	1179
Number of pages	1186
Journal	Tropical Journal of Natural Product Research
Volume	9
Issue number	3
DOIs	https://doi.org/10.26538/tjnpr/v9i3.38
State	Published - 2025/03/25

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.26538/tjnpr/v9i3.38License: CC BY-ND

Cite this

@article{f0fc9e8110fb4e48b205ee431cd26ebc,

title = "Comparison of the Metabolite Profiles of HT-29 Colorectal Cancer Cells Treated with Curcumin, Cisplatin, 5-Fluorouracil and Doxorubicin in a Metabolomic Approach",

author = "Ade Arsianti and Innas Widiasti and Aryo Tedjo and Shun Hirota and Hiroki Tanimoto",

year = "2025",

month = mar,

day = "25",

doi = "10.26538/tjnpr/v9i3.38",

language = "日本",

volume = "9",

pages = "1179",

journal = "Tropical Journal of Natural Product Research",

issn = "2616-0692",

number = "3",

}

TY - JOUR

T1 - Comparison of the Metabolite Profiles of HT-29 Colorectal Cancer Cells Treated with Curcumin, Cisplatin, 5-Fluorouracil and Doxorubicin in a Metabolomic Approach

AU - Arsianti, Ade

AU - Widiasti, Innas

AU - Tedjo, Aryo

AU - Hirota, Shun

AU - Tanimoto, Hiroki

PY - 2025/3/25

Y1 - 2025/3/25

U2 - 10.26538/tjnpr/v9i3.38

DO - 10.26538/tjnpr/v9i3.38

M3 - 学術論文

SN - 2616-0692

VL - 9

SP - 1179

JO - Tropical Journal of Natural Product Research

JF - Tropical Journal of Natural Product Research

IS - 3

ER -